Transcription by RNA polymerases I and III: A potential link between cell growth, protein synthesis and the retinoblastoma protein

Journal of Molecular Medicine

Volumn 76, Issue 2, 1998, Pages 94-103

  Larminie, Christopher G C ^a,b   Alzuherri, Hadi M ^b   Cairns, Carol A ^b   McLees, Angela ^b   White, Robert J ^b,c,d,e  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d WELLCOME CRC INSTITUTE   (United Kingdom)

^e Lister Institute of Preventive Medicine   (United Kingdom)

Author keywords

Cancer; Retinoblastoma; Transcription; Translation; Tumour suppression

Indexed keywords

DNA DIRECTED RNA POLYMERASE; DNA DIRECTED RNA POLYMERASE III; RETINOBLASTOMA PROTEIN;

CELL GROWTH; CELL TRANSFORMATION; GENETIC TRANSCRIPTION; MALIGNANT TRANSFORMATION; PROTEIN SYNTHESIS; REVIEW; TUMOR GROWTH;

ANIMALS; CELL DIVISION; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; PROTEIN BIOSYNTHESIS; RETINOBLASTOMA PROTEIN; RNA POLYMERASE I; RNA POLYMERASE III; TRANSCRIPTION, GENETIC;

EID: 0031906160     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050196     Document Type: Review

References (117)

1. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323-330
2. Whyte P (1995) The retinoblastoma protein and its relatives. Semin Cancer Biol 6:83-90
3. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Alberts DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646
4. Huang H-JS, Yee J-K, Shew J-Y, Chen P-L, Bookstein R, Friedmann T, Lee EY-HP, Lee W-H (1988) Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1563-1566
5. Bookstein R, Shew J, Chen P, Scully P, Lee W (1990) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712-715
6. Qin X, Chittenden T, Livingston DM, Kaelin WG (1992) Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dcv 6:953-964
7. Clarke AR, Maandag ER, van Roon M, van der Lugt NM T, van der Valk M, Hooper ML, Berns A, te Riele H (1992) Requirement for a functional Rb-I gene in murine development. Nature 359:328-330
8. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359:295-300
9. Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294
10. Δ20/+ mice are predisposed to tumours of the pituitary gland with a nearly complete penetrance. Oncogene 9:1021-1027
11. Maandag EC R, van der Valk M, Vlaar M, Feltkamp C, O'Brien J, van Roon M, van der Lugt N, Berns A, te Riele H (1994) Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J 13:4260-4268
12. Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RA, Jacks T (1994) Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J 13:4251-4259
13. +/ mice. Genes Dev 10:1870-1879
14. Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246:603-608
15. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551-555
16. Horowitz JM, Park S-H, Bogenmann E, Cheng J-C, Yandell DW, Kaye FJ, Minna JD, Dryja TP, Weinberg RA (1990) Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumour cells. Proc Natl Acad Sci USA 87:2775-2779
17. Scheffner M, Munger K, Byrne JC, Howley PM (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527
18. Vousden KH (1995) Regulation of the cell cycle by viral oncoproteins. Semin Cancer Biol 6:109-116
19. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937
20. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumour suppressor gene product. EMBO J 8:4099-4105
21. Heck DV, Yee CL, Howley PM, Munger K (1992) Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci USA 89:4442-4446
22. Sang B-C, Barbosa MS (1992) Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins. Proc Natl Acad Sci USA 89:8063-8067
23. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124-129
24. Whyte P, Williamson NM, Harlow E (1989) Cellular targets for transformation by the adenovirus E1A proteins. Cell 56:67-75
25. DeCaprio JA, Ludlow JW, Figge J, Shew J-Y, Huang C-M, Lee W-H, Marsilio E, Paueha E, Livingston DM (1988) SV40 large tumour antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283
26. Moran E (1988) A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products. Nature 334:168-170
27. Rb and a second cellular protein, p120. Cell 58:257-267
28. Ludlow JW, DeCaprio JA, Huang C-M, Lee W-H, Paucha E, Livingston DM (1989) SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56:57-65
29. Hu Q, Dyson N, Harlow E (1990) The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J 9:1147-1155
30. Hunter T, Pines J (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582
31. Pines J (1995) Cyclins, CDKs and cancer. Semin Cancer Biol 6:63-72
32. Bates S, Peters G (1995) Cyclin D1 as a cellular proto-oncogene, Semin Cancer Biol 6:73-82
33. Sinclair AJ, Palmero I, Peters G, Farrell PJ (1994) EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B-lymphocytes by Epstein-Barr virus. EMBO J 13:3321-3328
34. Hirama T, Koeffler HP (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841-854
35. Ink4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9:3375-3378
36. Willis IM (1993) RNA polymerase III. Genes, factors and transcriptional specificity. Eur J Biochem 212:1-11
37. White RJ (1994) RNA polymerase III transcription. Landes, Austin
38. + RNA. Nucleic Acids Res 10:7477-7491
39. Brickell PM, Latchman DS, Murphy D, Willison K, Rigby PW J (1983) Activation of a Qa/Tla class I major histocompatibility antigen gene is a general feature of oncogenesis in the mouse. Nature 306:756-760
40. Scott MRD, Westphal K-H, Rigby PWJ (1983) Activation of mouse genes in transformed cells. Cell 34:557-567
41. Majello B, La Mantia G, Simeone A, Boncinelli E, Lania L (1985) Activation of major histocompatibility complex class I mRNA containing an Alu-like repeat in polyoma virus-transformed rat cells. Nature 314:457-459
42. + RNA from mouse tissues. FEBS Lett 182:73-76
43. Singh K, Carey M, Saragosti S, Botchan M (1985) Expression of enhanced levels of small RNA polymerase III transcripts encoded by the B2 repeats in simian virus 40-transformed mouse cells. Nature 314:553-556
44. Carey MF, Singh K, Botchan M, Cozzarelli NR (1986) Induction of specific transcription by RNA polymerase III in transformed cells. Mol Cell Biol 6:3068-3076
45. Lania L, Pannuti A, La Mantia G, Basilico C (1987) The transcription of B2 repeated sequences is regulated during the transition from quiescent to proliferative state in cultured rodent cells. FEBS Lett 219:400-404
46. Carey MF, Singh K (1988) Enhanced B2 transcription in simian virus 40-transformed cells is mediated through the formation of RNA polymerase III transcription complexes on previously inactive genes. Proc Natl Acad Sci USA 85:7059-7063
47. + RNAs are transcribed by RNA polymerase III in murine tumor cells. Nucleic Acids Res 18:4499-4506
48. White RJ, Stott D, Rigby PWJ (1990) Regulation of RNA polymerase III transcription in response to Simian virus 40 transformation. EMBO J 9:3713-3721
49. White RJ, Trouche D, Martin K, Jackson SP, Kouzarides T (1996) Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature 382:88-90
50. Larminie CGC, Cairns CA, Mital R, Martin K, Kouzarides T, Jackson SP, White RJ (1997) Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J 16:2061-2071
51. Rigby PWJ (1993) Three in one and one in three: it all depends on TBP. Cell 72:7-10
52. Kassavetis GA, Braun BR, Nguyen LH, Geiduschek EP (1990) S. cerevisiae TFIIIB is the transcription initiation factor proper of RNA polymerase III, while TFIIIA and TFIIIC are assembly factors. Cell 60:235-245
53. White RJ, Gottlieb TM, Downes CS, Jackson SP (1995) Cell cycle regulation of RNA polymerase III transcription. Mol Cell Biol 15:6653-6662
54. Kaye FJ, Kratzke RA, Gerster JL, Horowitz JM (1990) A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci USA 87:6922-6926
55. Loeken M, Bikel I, Livingston DM, Brady J (1988) Trans-activation of RNA polymerase II and III promoters by SV40 small t antigen. Cell 55:1171-1177
56. Patel G, Jones NC (1990) Activation in vitro of RNA polymerase II and III directed transcription by baculovirus produced E1A protein. Nucleic Acids Res 18:2909-2915
57. Cavanaugh AH, Hempel WM, Taylor LJ, Rogalsky V, Todorov G, Rothblum LI (1995) Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature 374:177-180
58. Reeder RH, Pikaard CS, McStay B (1995) UBF, an architectural element for RNA polymerase I promoters. Nucleic Acids Mol Biol 9:251-263
59. Shan B, Zhu X, Chen P-L, Durfee T, Yang Y, Sharp D, Lee W-H (1992) Molecular cloning of cellular genes encoding retinoblastoma-asociated proteins: identification of a gene with properties of the transcription factor E2F. Mol Cell Biol 12:5620-5631
60. Liebhaber SA, Wolf S, Schlessinger D (1978) Differences in rRNA metabolism of primary and SV40-transformed human fibroblasts. Cell 13:121-127
61. Learned RM, Smale S, Haltiner M, Tjian R (1983) Regulation of human ribosomal RNA transcription. Proc Natl Acad Sei USA 80:3558-3562
62. Rucckert RR, Mueller GC (1960) Studies on unbalanced growth in tissue culture, I. Induction and consequences of thymidine deficiency. Cancer Res 20:1584-1592
63. Kung AL, Sherwood SW, Schimke RT (1993) Differences in the regulation of protein synthesis, cyclin B accumulation, and cellular growth in response to the inhibition of DNA synthesis in Chinese hamster ovary and Hela S3 cells. J Biol Chem 268:23072-23080
64. Shan B, Lee W-H (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14:8166-8173
65. Qin X-Q, Livingston DM, Kaelin WG, Adams PD (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91:10918-10922
66. Stanners CP, Adams ME, Harkins JL, Pollard JW (1979) Transformed cells have lost control of ribosome number through their growih cycle. J Cell Physiol 100:127-138
67. Lam EW-F, La Thangue NB (1994) DP and E2F proteins: coordinating transcription with cell cycle progression. Curr Opin Cell Biol 6:859-866
68. La Thangue NB (1994) DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci 19:108-114
69. Adams PD, Kaelin WG (1995) Transcriptional control by E2F, Semin Cancer Biol 6:99-108
70. Weinberg RA (1996) E2F and cell proliferation: a world turned upside down. Cell 85:457-459
71. Nasmytb K (1996) Another role rolls in. Nature 382:28-29
72. Nurse P (1975) Genetic control of cell size at cell division in yeast. Nature 256, 547-551
73. + gene of S, cerevisiae tethers cell division to cell size and is a cyclin homolog. EMBO J 7:4335-4346
74. Killander D, Zetterberg A (1965) A quantitative cytochemical investigation of the relationship between cell mass and initiation of DNA synthesis in mouse fibroblasts in vitro. Exp Cell Res 40:12-20
75. White RJ (1997) Regulation of RNA polymerases I and III by the retinoblastoma protein: a mechanism for growth control? Trends Biochem Sci 22:77-80
76. Johnson LF, Abelson HT, Green H, Penman S (1974) Changes in RNA in relation to growth of the fibroblast. I. Amounts of mRNA, rRNA, and tRNA in resting and growing cells. Cell 1:95-100
77. Mauck JC, Green H (1974) Regulation of pre-transfer RNA synthesis during transition from resting to growing state. Cell 3:171-177
78. Kief DR, Warner JR (1981) Coordinate control of syntheses of ribosomal ribonucleic acid and ribosomal proteins during nutritional shift-up in Saccharomyces cerevisiae. Mol Cell Biol 1:1007-1015
79. Tatsuka M, Mitsui H, Wada M, Nagata A, Nojima H, Okayama H (1992) Elongation factor-1α gene determines suscep-tibility to transformation. Nature 359:333-335
80. Redpath NT, Proud CG (1994) Molecular mechanisms in the control of translation by hormones and growth factors. Biochim Biophys Acta 1220:147-162
81. Clarke EM, Peterson CL, Brainard AV, Riggs DL (1996) Regulation of the RNA polymerase I and III transcription systems in response to growth conditions. J Biol Chem 271: 22189-22195
82. Rosenwald IB (1996) Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2α in transformed cells. Cancer Lett 102:113-123
83. Rosenwald IB (1996) Deregulation of protein synthesis as a mechanism of neoplastic transformation. Bioessays 18:243-250
84. Baxter GC, Stanners CP (1978) The effect of protein degradation on cellular growth characteristics. J Cell Physiol 96:139-146
85. Brooks RF (1977) Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell 12:311-317
86. Ronning OW, Lindmo T, Pettersen EO, Seglen PO (1981) The role of protein accumulation in the cell cycle control of human NHIK 3035 cells. J Cell Physiol 109:411-418
87. Hiebert SW, Lipp M, Nevins JR (1989) E1 A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci USA 86:3594-3598
88. Zou X, Rudchenko S, Wong K, Calame K (1997) Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Rafl, and cyclin-dependent kinases. Genes Dev 11:654-662
89. Rosenwald IB, Rhoads DB, Callanan ID, Isselbacher KJ, Schmidt EV (1993) Increased expression of translation initiation factors eIF-4E and eIF-2Κ in response to growth induction by c-myc. Proc Natl Acad Sci USA 90:6175-6178
90. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV (1993) Elevated expression of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 13:7358-7363
91. Jones RM, Branda J, Johnston KA, Polymenis M, Gadd M, Rustgi A, Callanan L, Schmidt EV (1996) An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol Cell Biol 16:4754-4764
92. Duncan R, Milburn SC, Hershey JW (1987) Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggests a role in translational control. Heat shock effects on eIF-4F. J Biol Chem 262:380-388
93. 1 cyclincdk complexes. EMBO J 14:4814-1826
94. Galaktionov K, Chen X, Beach D (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517
95. 1. Nature 328:445-449
96. Prochownik EV, Kukowska J, Rodgers C (1988) c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukaemia cells. Mol Cell Biol 8:3683-3695
97. Herrera RE, Sah VP, Williams BO, Makela TP, Weinberg RA, Jacks T (1996) Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol 16:2402-2407.
98. Pogue-Geile K, Geiser JR, Shu M, Miller C, Wool IG, Meisler AI, Pipas JM (1991) Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol 11:3842-3849
99. Lazaris-Karatzas A, Montine KS, Sonenberg N (1990) Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345:544-546
100. Lazaris-Karatzas A, Sonenberg N (1992) The mRNA 5′ cap-binding protein. eIF-4E, cooperates with v-myc or EIA in the transformation of primary rodent fibroblasts. Mol Cell Biol 12:1234-1238
101. De Benedetti A, Rhoads RE (1990) Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in abberant growth and morphology. Proc Natl Acad Sci USA 87:8212-8216
102. De Benedetti A, Joshi-Barve S, Rinker-Schaffer C, Rhoads RE (1991) Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates and reduced levels of both eIF-4E and p220 component of eIF-4F. Mol Cell Biol 11:5435-5445
103. Rinkerr-Schaffer CW, Graff JR, De Benedetti A, Zimmer SG, Rhoads RE (1993) Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int J Cancer 55:841-847
104. Donze O, Jagus R, Koromilas AE, Hershey JWB. and Sonenberg N (1995) Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 14:3828-3834
105. Chong KL, Feng L, Schappert K, Meurs E, Donahue TF, Friesen JD, Hovanessian AG, Williams BRG (1992) Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J 11:1553-1562
106. Koromilas AE, Roy S, Barber GN, Katze MG, Sonenberg N (1992) Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257:1685-1689
107. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG (1993) Tumour suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90:232-236
108. Clemens M (1992) Suppression with a difference. Nature 360:210-211
109. Lengyel P (1993) Tumour-suppressor genes: news about the interferon connection. Proc Natl Acad Sci USA 90:5893-5895
110. Rosenwald IB (1995) Growth-factor independent expression of the gene encoding eukaryotic translation initiation factor 4E in transformed cell lines. Cancer Lett 98:77-82
111. Frederickson RM, Montine KS, Sonenberg N (1991) Phosphorylation of eukaryotic translation initiation factor 4E is increased in src-transformed cell lines. Mol Cell Biol 11:2896-2900
112. Rinker-Schaeffer CW, Austin V, Zimmer S, Rhoads RE (1992) Ras transformation of cloned rat embryo fibroblasts results in increased rates of protein synthesis and phosphorylation of eukaryotic initiation factor 4E. J Biol Chem 267:10659-10664
113. Mundschau LJ, Faller DV (1992) Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2α-kinase activation. J Biol Chem 267:23092-23098
114. Taya Y (1997) RB kinases and RB-binding proteins: new points of view. Trends Biochem Sci 22:14-17
115. Welch PJ, Wang JYJ (1993) A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779-790
116. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP (1994) The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119-130
117. Singh P, Coe J, Hong W (1995) A role tor retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374:562-565